Polaris Venture Management Co. V, L.L.C.'s Net Worth

$177 Million

Who is Polaris Venture Management Co. V, L.L.C.?

Polaris Venture Management Co. V, L.L.C. has an estimated net worth of $177 Million. This is based on reported shares across multiple companies, which include Phreesia, Inc., BIND Therapeutics, Inc, Adagio Therapeutics, Inc., Cardlytics, Inc., Pulmatrix, Inc., OCULAR THERAPEUTIX, INC, FATE THERAPEUTICS INC, TREVENA INC, GENOCEA BIOSCIENCES, INC., SELECTA BIOSCIENCES INC, Cerulean Pharma Inc., Lyra Therapeutics, Inc., Kala Pharmaceuticals, Inc., T2 Biosystems, Inc., aTYR PHARMA INC, Arsanis, Inc., and INTERNET BRANDS, INC..

SEC CIK

Polaris Venture Management Co. V, L.L.C.'s CIK is 0001439589

Past Insider Trading and Trends

2018 was Polaris Venture Management Co. V, L.L.C.'s most active year for acquiring shares with 54 total transactions. Polaris Venture Management Co. V, L.L.C.'s most active month to acquire stocks was the month of January. 2015 was Polaris Venture Management Co. V, L.L.C.'s most active year for disposing of shares, totalling 128 transactions. Polaris Venture Management Co. V, L.L.C.'s most active month to dispose stocks was the month of June. 2014 saw Polaris Venture Management Co. V, L.L.C. paying a total of $16,944,749.00 for 14,682,469 shares, this is the most they've acquired in one year. In 2015 Polaris Venture Management Co. V, L.L.C. cashed out on 15,642,290 shares for a total of $21,694,891.32, their largest year based on trade value.